Clinical Trials in New York

Showing 16661-16680 of 22,668 trials

A Laboratory Model for Heroin Abuse Medications - 8

NCT00000273

The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."

Heroin DependenceOpioid-Related DisordersSubstance-Related Disorders

New York State Psychiatric Institute8 participantsStarted Aug 1995

New York, New York, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Study of IDN-6556 in Subjects With Liver Cirrhosis

NCT02230670

This is a multicenter study to see if treatment with IDN-6556 can help improve the liver function of patients with liver cirrhosis with Model for End-Stage Liver Disease scores between 11-18.

Liver CirrhosisHepatic Cirrhosis

Conatus Pharmaceuticals Inc.87 participantsStarted Aug 2014

Birmingham, Alabama, United States • La Jolla, California, United States • Loma Linda, California, United States +25 more locations

A Laboratory Model for Heroin Abuse Medications - 8

A Study of IDN-6556 in Subjects With Liver Cirrhosis

Find Trials by Condition in New York

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Pilot Study of Atorvastatin for Orthopedic Surgery Patients

Views of Cancer Patients Regarding Financial Conflicts of Interest

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Neuropsychological Evaluation of Psychiatric and Neurological Patients

Characterization of Childhood-Onset Obsessive-Compulsive Disorder

Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy

Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

Cogmed for Working Memory After TBI

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1

Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein

Genes Causing Ebstein's Anomaly

Evolution® Biliary Stent System-Fully Covered